Allovir Inc (ALVR) Stock: What Does the Chart Say Monday?

Allovir Inc (ALVR) stock is higher by 26.67% over the past week and gets a Bullish rating from InvestorsObserver Sentiment Indicator.

Allovir Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on ALVR!

See Full ALVR Report

What is Stock Sentiment?

In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company. Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive. InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend. Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .

What's Happening With ALVR Stock Today?

Allovir Inc (ALVR) stock is trading at $3.61 as of 12:37 PM on Monday, Aug 21, a gain of $0.77, or 27.11% from the previous closing price of $2.84. The stock has traded between $2.81 and $3.64 so far today. Volume today is more active than usual. So far 2,290,082 shares have traded compared to average volume of 583,278 shares. To see InvestorsObserver's Sentiment Score for Allovir Inc click here.

More About Allovir Inc

AlloVir Inc is a late clinical-stage cell therapy company. It is developing allogeneic T cell therapies to treat and prevent devastating viral diseases. The firm's pipeline includes ALVR106, ALVR109, ALVR108, and others. The company's product candidate, Viralym-M, is a multi-VST therapy targeting five viruses namely BK virus, cytomegalovirus, adenovirus, Epstein-Barr virus, and human herpesvirus 6. Click Here to get the full Stock Report for Allovir Inc stock.